Victor Koteliansky - Concepedia

Author

Victor Koteliansky

Also Known As

Koteliansky, Victor, Koteliansky, Victor E., Victor E Koteliansky, Victor E. KOTELIANSKY, Victor E. Koteliansky, Victor Koteliansky

159

Publications

34.7K

Citations

H-Index

177

Concepts

All Affiliations

Biogen (United States)Massachusetts Institute of Technology Alnylam Pharmaceuticals (United States)Skolkovo Institute of Science and Technology Harvard University

About

Victor Koteliansky is an author at Biogen (United States) specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	46	70	18.4K
2	Engineering	13	14	7.8K
3	Natural Sciences	11	12	2.9K
4	Health Sciences	9	9	2.3K
5	Allergy	1	1	82

Victor Koteliansky

126

Publications

31.1K

Citations

H-Index

Page 1

	Year	Citations
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts Thomas Thum, Carina Gross, Jan Fiedler, Nature FibrosisMicrorna-21 ContributesMyocardial DiseasePathologyVascular Biology	2008	2.3K
Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter Joshua M. Baughman, Fabiana Perocchi, Hany S. Girgis, Nature Molecular PhysiologyMitochondrial FunctionNatural SciencesGeneticsDna Replication	2011	1.9K
Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape Jérôme Gilleron, William Querbes, Anja Zeigerer, Nature Biotechnology NanomedicineEngineeringEndosomal EscapeTargeted Drug DeliveryPharmaceutical Nanotechnology	2013	1.5K
RNAi-mediated gene silencing in non-human primates Tracy Zimmermann, Amy C. H. Lee, Akin Akinc, Nature GeneticsRnai-mediated GeneAntisense TherapyGene Expression	2006	1.3K
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics Akin Akinc, Andreas Zumbuehl, Michael S. Goldberg, Nature Biotechnology Cell-based Drug DeliveryNanomedicineLipid PreparationEngineeringRnai Therapeutics	2008	1.2K
From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus Alanna Strong, Maria Frank-Kamenetsky, Noemi E Lee, Nature Cholesterol LocusLipid DisorderAllelic VariantMedicineGenetics	2010	1.2K
Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms Akin Akinc, William Querbes, Soma De, Molecular Therapy NanotherapeuticsEngineeringImmunologyLipid NanoparticlesMolecular Biology	2010	1.1K
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs Christian Wolfrum, Shuanping Shi, K. N. Jayaprakash, Nature Biotechnology Cell-based Drug DeliveryNanomedicineEngineeringBiochemistryNano-drug Delivery	2007	958
Lipid-like materials for low-dose, in vivo gene silencing Kevin T. Love, Kerry P. Mahon, Christopher G. Levins, Proceedings of the National Academy of Sciences In Vivo Gene TherapyImmunologyGene DeliveryBiomedical EngineeringTherapeutics	2010	952
Interleukin-13 Induces Tissue Fibrosis by Selectively Stimulating and Activating Transforming Growth Factor β1 Chun Geun Lee, Robert Homer, Zhou Zhu, The Journal of Experimental Medicine	2001	920

Page 1